-
Notifications
You must be signed in to change notification settings - Fork 10
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
inferring MFs from annotations to complex portal IDs to individual complex participants #1662
Comments
Initial thoughts from breakout group:
|
GO-CAM models of different types of complexes and associated functions of their respective members are here: http://noctua.berkeleybop.org/editor/graph/gomodel:59c8885900000281 These are proposed models for different types of use cases, but we will likely want to model more before coming to any decisions. Note that the rules for GPAD annotation outputs have not been formulated yet, so what is currently in the annotation preview is not final. |
related to #1661 Collecting use cases here: |
After discussing this for a little while yesterday (30/11/17) we decided it would be good to get user input to what they need/want.
|
I've tried to summarise the situation regarding the way we extract annotations from complexes and from individual GPs: Along the black lines, the top relationships are those used currently, the ones added in red pen are the ones we are discussing. Points:
Please review the picture and post your MF class related comments here. Please post CC class related comments in #1639 |
geneontology/go-ontology#14847 |
Call from 13/2: We need to have examples of a complex: |
@ValWood @RLovering @ukemi @sylvainpoux @vanaukenk Collecting use cases here: Draft survey: Thanks. |
Minutes from WG call on 22/2/18: Present: Sides: Complex Names: **Use of contributes_to **:
$ regulatory subunits: any GP (protein or otherwise) that has not been identified to be carrying out the enzymatic activity of the complex but are consistently found as complex member. They may or may not be essential (we don't distinguish essential subunits in the CP as most experiments don't go into that detail consistently).
Ruth: What about homodimers? Annotate directly. Summary:
Rational WHY I want to do this:
Summary from GOC meeting in Cambridge (Oct 2017): Val: Annotations on Gene Pages link MFs to complexes using occurs_in Ruth (initial gut feeling): export for catalytic subunits but not regulatory subunits. Birgit: Who would use these annotations??? What do they really need??? NO SOLUTION YET!!!
Going forward: @judyblake (@hdrabkin /@deustp01 ) to pass on details of users to Birgit, Birgit to get some feedback before next call (8/3/18). Birgit (I've probably forgotten something or someone so please add your comments. I'll be updating the contributes_to guideline ticket later.) |
Ok, forgot one thing: "X binding": So far we have discussed what to do with catalytic activity but we also have MF annotations to "binding". We don't use "protein/complex" binding, that sort of data is captured by IntAct and exported from there, but any other type of "binding", e.g.: Caveat: "Homework" for everyone: Think about binding terms that the user might want/need. @RLovering can you think about this in the context of GREEKC, please? |
Not discussed on the call:
but I'll run the issues by the users as well when I speak to them. |
Example for homodimers: PDGF ligands come in 5 flavours: AA, AB, BB, CC, DD. And, the receptors (alpha-alpha, beta-beta or alpha-beta) don't dimerise until the ligand complex binds, forming an obligate heterotetrameric receptor-ligand complex! So, the activities rely both on the dimeric ligand and the tetrameric receptor-ligand. Food for thought how you would annotate that! Added to google doc as well. |
Google sheet for list of GPs as participants of catalytic complexes and their biol role annotations in the CP: |
Summary from call on 15/3/18: Present: Lauren-Philip, Pascale, Peter, Edith, Kimberly, Harold, Val, Tanya, Ruth, Sandra, Birgit Lauren-Philip has a protein-protein interaction background and introduced his interest in complexes as drug targets.
We looked through the Google sheet that contains all GPs from complexes annotated to "catalytic activity" and split by their biological roles: enzyme, enzyme regulator and unspecified role. Points to consider:
Decision 1: Thought: can we capture the "regulator activity" by walking through the ontology? E.g. CPX-1001(EBI-13638510) Calcineurin-Calmodulin complex, gamma-R1 variant Decision 2:
Decision 3: Thank you all for your valuable input!!! I have something to work on now (well, Noe and Tony :) ) |
Update: Rather than sending papers with missing GP annotation evidence to MODs we could add those directly through P2GO --> AI: Complex curators to be trained in P2GO! |
Update from NYU GOC mtg: What do we do if there are 2 or more enzyme subunits and 2 or more function annotations on one complex? A script doesn't know which subunit has which function. --> Manually annotate in P2GO? |
This translation is now done. GO MFs are NOT inferred from Intact/Complex portal annotations, only BPs. |
Follow up from GOC meeting in Cambridge 2017:
The working group agreed that the CC (but see #1639 with regards to the required qualifiers!) and BP annotations would be equally appropriate for the complex subunits as they are for the complex so we'll extract them in the new Complex Portal GDAP.
However, extrapolating to MF is tricky:
We decided that we could infer the activity of the active subunit if it has been annotated as 'enzyme' in the CP. However, we could we also extrapolate something about the in-active complex members. In the past people used contributes_to but it has been proposed that this relationship should be obsolete or at least used with great care (#1650 - proposal guidelines). Can we say anything else about the MF of an inactive complex member?
Please post your use cases and proposals here.
The text was updated successfully, but these errors were encountered: